期刊
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
卷 151, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.ejps.2020.105411
关键词
Rifampicin elastic liposomes; Transdermal permeation; Mechanistic evaluation; Pharmacokinetics; GastroPlus(TM) prediction and; simulation
资金
- Deanship of Scientific Research at King Saud University [RG-1441-462]
This study investigated enhanced bioavailability and sustained delivery of transdermally delivered rifampicin (RIF) in elastic liposomes (ELs). F3, F5, and F7 were optimized formulations comprising of 200, 140 and 80 mg of tween 80, respectively, and Phospholipon((R)) 90 G (300 mg). They were optimized based on in vitro and ex vivo parameters. Using the Franz diffusion cell, an ex vivo study was conducted by utilizing the rat skin for permeation profiles. Also, pharmacokinetic parameters, mechanistic evaluation of penetration, and histopathological investigation were conducted in the rat model for complete dynamic evaluations. Vesicle sizes of suspensions and gels were found to be similar whereas zeta potential of gel attained more negativity due to acidic carbopol. Permeation parameters of gels were significantly (p < 0.05) higher compared to respective ELs due to increased residence time and the composition of the formulations (ethanol, tween 80, D-limonene and lipid). Bioavailability of RIF (F5 gel) was improved by transdermal absorption as evidenced with AUC(0 -> 24) of transdermal F5 gel (56.23 +/- 2.7 mu g.hr/mL) and oral drug suspension (41.71 +/- 5.2 mu g.hr/mL). A lower value of transdermal C-max (6.9 +/- 0.8 mu g/mL) validated sustained delivery for improved tuberculosis management than oral delivery (10.5 +/- 1.46.9 +/- 0.8 mu g/mL). In vivo skin interaction, biopsy and in silico prediction studies corroborated suitable alternative for sustained and prolonged delivery of RIF with high patient compliance to control cutaneous tuberculosis and related infections.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据